Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H24O6 |
Molecular Weight | 384.4224 |
Optical Activity | UNSPECIFIED |
Additional Stereochemistry | Yes |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
Stereo Comments | AXIAL, S |
SHOW SMILES / InChI
SMILES
COC1=C2OCOC2=CC3=C1C4=C(C[C@@H](C)[C@@H](C)C3)C=C5OCOC5=C4OC
InChI
InChIKey=HTBWBWWADZJXID-TXEJJXNPSA-N
InChI=1S/C22H24O6/c1-11-5-13-7-15-19(27-9-25-15)21(23-3)17(13)18-14(6-12(11)2)8-16-20(22(18)24-4)28-10-26-16/h7-8,11-12H,5-6,9-10H2,1-4H3/t11-,12+
Molecular Formula | C22H24O6 |
Molecular Weight | 384.4224 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Schisandrins (schizandrins) are a group of bioactive chemical compounds found in Schisandra chinensis, one member of which is Schisandrin C. Schizandrin C exerts anti-neuroinflammatory effects by upregulating phase II detoxifying/antioxidant enzymes via cAMP/PKA/CREB and Nrf-2 signaling. Also was shown, that among human hepatocellular carcinoma cells (Bel-7402), human breast cancer cells (Bcap37) and human nasopharyngeal carcinoma cells (KB-3-1), Bel-7402 cells were most sensitive with IC50 equal to 81.58 ± 1.06 μ M after treatment with schisandrin C. Although the mechanism of tumor inhibiting activity of schisandrin C is not clarified, there are some reports about dibenzocyclooctadiene lignans inducing cancer cell apoptosis. Further investigations are needed to determine in more detail the molecular mechanism, such as the dependent pathway of this apoptotic process, the signal transduction pathways involved and the possible changes in expression of other apoptosis-related genes. Recently was also speculated, that Schisandrin C offered protection against Aβ1-42 -induced dysfunction in learning and memory by inhibiting total cholinesterase and its antioxidant action.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9271337
mice: 1 mmol/kg at day, 3 days
Route of Administration:
Other
In Vitro Use Guide
Sources: http://dx.doi.org/10.1080/13880200802370399
Among human hepatocelluar carcinoma cells (Bel-7402), human breast cancer cells (Bcap37) and human nasopharyngeal carcinoma cells (KB-3-1), Bel-7402 cells were most sensitive with IC50 equal to 81.58 ± 1.06 μ M after treatment with schisandrin C for 48 h. Cytotoxicity of schisandrin C on tumor cells depends on cellular accumulation of the drug. Cells were placed within 96-well culture plates (104 cells/well) respectively, and allowed to attach for 24 h before treatment. The cells were treated with schisandrin C ranging from 12.5 to 200 μ m or without (vehicle control, 0.5% DMSO) schisandrin C for cell lines. Schisandrin C cytotoxicity was measured after 48 h of culture using the MTT assay.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:51:21 GMT 2023
by
admin
on
Sat Dec 16 10:51:21 GMT 2023
|
Record UNII |
C8754W6B3G
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C8754W6B3G
Created by
admin on Sat Dec 16 10:51:21 GMT 2023 , Edited by admin on Sat Dec 16 10:51:21 GMT 2023
|
PRIMARY | |||
|
DTXSID101317497
Created by
admin on Sat Dec 16 10:51:21 GMT 2023 , Edited by admin on Sat Dec 16 10:51:21 GMT 2023
|
PRIMARY | |||
|
443027
Created by
admin on Sat Dec 16 10:51:21 GMT 2023 , Edited by admin on Sat Dec 16 10:51:21 GMT 2023
|
PRIMARY | |||
|
61301-33-5
Created by
admin on Sat Dec 16 10:51:21 GMT 2023 , Edited by admin on Sat Dec 16 10:51:21 GMT 2023
|
PRIMARY | |||
|
100000175519
Created by
admin on Sat Dec 16 10:51:21 GMT 2023 , Edited by admin on Sat Dec 16 10:51:21 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |